These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

448 related items for PubMed ID: 16951223

  • 1. Aberrant nuclear accumulation of glycogen synthase kinase-3beta in human pancreatic cancer: association with kinase activity and tumor dedifferentiation.
    Ougolkov AV, Fernandez-Zapico ME, Bilim VN, Smyrk TC, Chari ST, Billadeau DD.
    Clin Cancer Res; 2006 Sep 01; 12(17):5074-81. PubMed ID: 16951223
    [Abstract] [Full Text] [Related]

  • 2. Glycogen synthase kinase-3beta participates in nuclear factor kappaB-mediated gene transcription and cell survival in pancreatic cancer cells.
    Ougolkov AV, Fernandez-Zapico ME, Savoy DN, Urrutia RA, Billadeau DD.
    Cancer Res; 2005 Mar 15; 65(6):2076-81. PubMed ID: 15781615
    [Abstract] [Full Text] [Related]

  • 3. Maintenance of constitutive IkappaB kinase activity by glycogen synthase kinase-3alpha/beta in pancreatic cancer.
    Wilson W, Baldwin AS.
    Cancer Res; 2008 Oct 01; 68(19):8156-63. PubMed ID: 18829575
    [Abstract] [Full Text] [Related]

  • 4. Glycogen synthase kinase-3β, NF-κB signaling, and tumorigenesis of human osteosarcoma.
    Tang QL, Xie XB, Wang J, Chen Q, Han AJ, Zou CY, Yin JQ, Liu DW, Liang Y, Zhao ZQ, Yong BC, Zhang RH, Feng QS, Deng WG, Zhu XF, Zhou BP, Zeng YX, Shen JN, Kang T.
    J Natl Cancer Inst; 2012 May 16; 104(10):749-63. PubMed ID: 22534782
    [Abstract] [Full Text] [Related]

  • 5. Differential activity of GSK-3 isoforms regulates NF-κB and TRAIL- or TNFα induced apoptosis in pancreatic cancer cells.
    Zhang JS, Herreros-Villanueva M, Koenig A, Deng Z, de Narvajas AA, Gomez TS, Meng X, Bujanda L, Ellenrieder V, Li XK, Kaufmann SH, Billadeau DD.
    Cell Death Dis; 2014 Mar 27; 5(3):e1142. PubMed ID: 24675460
    [Abstract] [Full Text] [Related]

  • 6. Glycogen synthase kinase-3: a new therapeutic target in renal cell carcinoma.
    Bilim V, Ougolkov A, Yuuki K, Naito S, Kawazoe H, Muto A, Oya M, Billadeau D, Motoyama T, Tomita Y.
    Br J Cancer; 2009 Dec 15; 101(12):2005-14. PubMed ID: 19920820
    [Abstract] [Full Text] [Related]

  • 7. Glycogen synthase kinase-3beta: a prognostic marker and a potential therapeutic target in human bladder cancer.
    Naito S, Bilim V, Yuuki K, Ugolkov A, Motoyama T, Nagaoka A, Kato T, Tomita Y.
    Clin Cancer Res; 2010 Nov 01; 16(21):5124-32. PubMed ID: 20889919
    [Abstract] [Full Text] [Related]

  • 8. Glycogen synthase kinase-3β indirectly facilitates interferon-γ-induced nuclear factor-κB activation and nitric oxide biosynthesis.
    Kai JI, Huang WC, Tsai CC, Chang WT, Chen CL, Lin CF.
    J Cell Biochem; 2010 Dec 15; 111(6):1522-30. PubMed ID: 20872791
    [Abstract] [Full Text] [Related]

  • 9. ShRNA silencing glycogen synthase kinase-3 beta inhibits tumor growth and angiogenesis in pancreatic cancer.
    Zhou W, Wang L, Gou SM, Wang TL, Zhang M, Liu T, Wang CY.
    Cancer Lett; 2012 Mar 28; 316(2):178-86. PubMed ID: 22100174
    [Abstract] [Full Text] [Related]

  • 10. Troglitazone, a PPAR agonist, inhibits human prostate cancer cell growth through inactivation of NFκB via suppression of GSK-3β expression.
    Ban JO, Oh JH, Son SM, Won D, Song HS, Han SB, Moon DC, Kang KW, Song MJ, Hong JT.
    Cancer Biol Ther; 2011 Aug 15; 12(4):288-96. PubMed ID: 21613824
    [Abstract] [Full Text] [Related]

  • 11. Inhibition of GSK-3beta decreases NF-kappaB-dependent gene expression and impairs the rat liver regeneration.
    Chen H, Yang S, Yang Z, Ma L, Jiang D, Mao J, Jiao B, Cai Z.
    J Cell Biochem; 2007 Dec 01; 102(5):1281-9. PubMed ID: 17427960
    [Abstract] [Full Text] [Related]

  • 12. Inhibition of glycogen synthase kinase-3 beta induces apoptosis and mitotic catastrophe by disrupting centrosome regulation in cancer cells.
    Yoshino Y, Ishioka C.
    Sci Rep; 2015 Aug 21; 5():13249. PubMed ID: 26292722
    [Abstract] [Full Text] [Related]

  • 13. Glycogen synthase kinase-3 inhibition disrupts nuclear factor-kappaB activity in pancreatic cancer, but fails to sensitize to gemcitabine chemotherapy.
    Mamaghani S, Patel S, Hedley DW.
    BMC Cancer; 2009 Apr 30; 9():132. PubMed ID: 19405981
    [Abstract] [Full Text] [Related]

  • 14. Glycogen synthase kinase 3beta functions to specify gene-specific, NF-kappaB-dependent transcription.
    Steinbrecher KA, Wilson W, Cogswell PC, Baldwin AS.
    Mol Cell Biol; 2005 Oct 30; 25(19):8444-55. PubMed ID: 16166627
    [Abstract] [Full Text] [Related]

  • 15. Flavonoid apigenin modified gene expression associated with inflammation and cancer and induced apoptosis in human pancreatic cancer cells through inhibition of GSK-3β/NF-κB signaling cascade.
    Johnson JL, de Mejia EG.
    Mol Nutr Food Res; 2013 Dec 30; 57(12):2112-27. PubMed ID: 23943362
    [Abstract] [Full Text] [Related]

  • 16. Glycogen synthase kinase-3 inhibitor AR-A014418 suppresses pancreatic cancer cell growth via inhibition of GSK-3-mediated Notch1 expression.
    Kunnimalaiyaan S, Gamblin TC, Kunnimalaiyaan M.
    HPB (Oxford); 2015 Sep 30; 17(9):770-6. PubMed ID: 26147011
    [Abstract] [Full Text] [Related]

  • 17. Glycogen synthase kinase--3β inhibitors suppress leukemia cell growth.
    Song EY, Palladinetti P, Klamer G, Ko KH, Lindeman R, O'Brien TA, Dolnikov A.
    Exp Hematol; 2010 Oct 30; 38(10):908-921.e1. PubMed ID: 20540984
    [Abstract] [Full Text] [Related]

  • 18. Glycogen synthase kinase 3beta-mediated apoptosis of primary cortical astrocytes involves inhibition of nuclear factor kappaB signaling.
    Sanchez JF, Sniderhan LF, Williamson AL, Fan S, Chakraborty-Sett S, Maggirwar SB.
    Mol Cell Biol; 2003 Jul 30; 23(13):4649-62. PubMed ID: 12808104
    [Abstract] [Full Text] [Related]

  • 19. Inhibition of GSK-3beta mediates expression of MMP-9 through ERK1/2 activation and translocation of NF-kappaB in rat primary astrocyte.
    Kim SD, Yang SI, Kim HC, Shin CY, Ko KH.
    Brain Res; 2007 Dec 30; 1186():12-20. PubMed ID: 17996850
    [Abstract] [Full Text] [Related]

  • 20. Adiponectin modulates the glycogen synthase kinase-3beta/beta-catenin signaling pathway and attenuates mammary tumorigenesis of MDA-MB-231 cells in nude mice.
    Wang Y, Lam JB, Lam KS, Liu J, Lam MC, Hoo RL, Wu D, Cooper GJ, Xu A.
    Cancer Res; 2006 Dec 01; 66(23):11462-70. PubMed ID: 17145894
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.